rapamycin | Healthspan

(rapamycin)

07 / 19 / 2025•16 MIN READ

Suppressing Two Signals of Aging: Insights from the 2025 Rapamycin–Trametinib Study

07 / 11 / 2025•19 MIN READ

Targeting mTOR with Rapamycin Across Species: How Hypertrophic Cardiomyopathy Reversal in Cats Informs Human Cardiac Aging and Longevity

06 / 21 / 2025•29 MIN READ

The Case for Cyclical Longevity Protocols: How Rhythmic Activation of AMPK and Autophagy Reprograms Aging Cells

05 / 30 / 2025•32 MIN READ

The Mitochondrial Signature of Long COVID: What PRDX3 Is Trying to Tell Us—And How We Might Reverse It

01 / 25 / 2025•21 MIN READ

Mitochondria’s Paradoxical Role in Cancer Biology: Exploiting Metabolic Vulnerabilities for Therapeutic Targeting

01 / 11 / 2025•38 MIN READ

Connecting mTOR and Mitochondria: The Novel Synergy Between Rapamycin and Urolithin A

12 / 07 / 2024•25 MIN READ

Two Waves of Aging: How Midlife Biomolecular Shifts Accelerate Decline

10 / 12 / 2024•25 MIN READ

Targeting Inflammation and Bone Loss in Periodontal Disease with Low-Dose Rapamycin: A Review of Mechanisms and Clinical Potential

10 / 04 / 2024•7 MIN READ

Research Review: PEARL Study on Rapamycin for Age-Related Healthspan Improvements

06 / 29 / 2024•33 MIN READ

Optimizing Longevity Protocols: The Synergistic Potential of Rapamycin, Acarbose, and Metformin

06 / 22 / 2024•35 MIN READ

Regulating Anabolic and Catabolic Signaling for Healthspan Optimization: Impacts of Rapamycin, Exercise, and Testosterone Replacement Therapy

05 / 06 / 2024•2 MIN READ

Gethealthspan Featured in The Washington Post's Exploration of the Rapamycin's Potential

rapamycin | Healthspan